Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Healthcare Advertising Agencies
Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Mydecine Innovations Group Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by busy4lifeon Jan 05, 2017 10:38pm
104 Views
Post# 25673687

RE:RE:RE:Anyone heard of CMED - cannimed therapeutics

RE:RE:RE:Anyone heard of CMED - cannimed therapeuticsLOLLLLL..... let me guess... u think i am lying..... see my transaction below...... mark my words..... this will exceed CGC hands down..... I will send u some more info by email..... lets get off this board and keep it NF......


Jan 3, 2017 Buy CMED 1,600.00 11.14 Jan 3, 2017 ********
TFSA		 -17,830.95 CAD
  Description***CANNIMED THERAPEUTICS INC COM


Litemupp wrote: Seriously busy4life!!!!!! Is there anything u don't own. Seems like u have a pretty large basket of pot stocks. I am seriously considering CMED. Getting paid tomorrow and might throw in some money for 100 shares. Thx for ur comments and apologies for asking abt it here. CMED doesn't have a board yet.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities